国际标准期刊号: 2161-0681

临床与实验病理学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

The Role of C-Reactive Protein in Guiding Antibiotic Therapy: Is it Worth it?

Vandack Nobre* , Raphael Figuiredo Dias, Ursula Gramiscelli Hasparyk and Ana Clara Rivetti Bitencourt de Paula

The management of bacterial infections in hospitalized patients is a challenge in clinical practice and the decision-making process for initiating or discontinuing antimicrobial therapy is one of the main axes of this medical condition. This mini-review outlines the ideal features of an effective and safe circulating biomarker and provides valuable insights into the role of C-Reactive Protein (CRP) in the care of patients with suspected or confirmed bacterial infections, including those admitted to intensive care units. Furthermore, we highlight the importance of early intervention and appropriate antimicrobial use in this population and present some comparative data on Procalcitonin (PCT) and CRP as biomarkers to guide antibiotic therapy in hospitalized patients with bacterial infections.